Investigating the impact of gut microbiota-derived metabolites on benign prostatic hyperplasia using network pharmacology approaches. [PDF]
Xu Y +6 more
europepmc +1 more source
Blood inflammatory markers combined with tumor markers for differentiating benign prostatic hyperplasia from prostate cancer. [PDF]
Liu Z, Yang X, Hou X, Du P, Jia K.
europepmc +1 more source
A Narrative Review of Robotic Aquablation in Benign Prostatic Hyperplasia Care: Where We Are Now. [PDF]
Rahman ME +4 more
europepmc +1 more source
Aquablation for benign prostatic hyperplasia: real-world prostate size relevance and bleeding events across 6 years. [PDF]
Bitar M +7 more
europepmc +1 more source
Combined anatomical parameters predict benign prostatic hyperplasia-related lower urinary tract symptom severity: a volume-stratified study. [PDF]
Wang YX +7 more
europepmc +1 more source
Incidence and risk factors of LUTS associated with benign prostatic hyperplasia among Chinese men: findings from the CHARLS cohort. [PDF]
Lv C +10 more
europepmc +1 more source
Freehand Ultrasound-Guided Transperineal Microwave Ablation for Benign Prostatic Hyperplasia: A Novel Application. [PDF]
Ravizzini PIC +4 more
europepmc +1 more source
Evaluation of holmium laser enucleation of the prostate and bipolar transurethral resection of the prostate in relation to benign prostatic hyperplasia treatment. [PDF]
Ahmad A, Ranjan N, Dheeraj K, Babelay G.
europepmc +1 more source
Risk factors for benign prostatic hyperplasia: a comprehensive review. [PDF]
Siqueira MHB.
europepmc +1 more source

